Emilie Vomhof-DeKrey

Dr. Emilie Vomhof-DeKrey

University of North Dakota School Of Medicine And Health Sciences GRAND FORKS, ND, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2014 in Nature Immunology
Verified
Journal Article
Open access
PDF file
LLLydia Lynch
Lydia Lynch
XMXavier Michelet
Xavier Michelet
SZSai Zhang
Sai Zhang
PBPatrick J Brennan
Patrick J Brennan
AMAshley Moseman
Ashley Moseman
MBMichael B Brenner
Michael B Brenner
INKT cells in adipose tissue are anti-inflammatory. Brenner and colleagues show that adipose iNKT cells have a unique transcriptional program, produce IL-2 and IL-10 and lack expression of the transcription factor PLZF. Invariant natural killer T cells (iNKT cells) are lipid-sensing innate T cells that are restricted by the antigen-presenting molecule CD1d and express the transcription factor PLZF. iNKT cells accumulate in adipose tissue, where they are anti-inflammatory, but the factors that contribute to their anti-inflammatory nature, as well as their targets in adipose tissue, are unknown. Here we found that iNKT cells in adipose tissue had a unique transcriptional program and produced interleukin 2 (IL-2) and IL-10. Unlike other iNKT cells, they lacked PLZF but expressed the transcription factor E4BP4, which controlled their IL-10 production. The adipose iNKT cells were a tissue-resident population that induced an anti-inflammatory phenotype in macrophages and, through the production of IL-2, controlled the number, proliferation and suppressor function of regulatory T cells (Treg cells) in adipose tissue. Thus, iNKT cells in adipose tissue are unique regulators of immunological homeostasis in this tissue.

1 October 2012 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
EVEmilie Vomhof-DeKrey
Emilie Vomhof-DeKrey
MPMatthew J. Picklo
Matthew J. Picklo

1 February 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
TCTimothy Casselli
Timothy Casselli
ADAli Divan
Ali Divan
EVEmilie Vomhof-DeKrey
Emilie Vomhof-DeKrey
YTYvonne Tourand
Yvonne Tourand
HPHeidi L. Pecoraro
Heidi L. Pecoraro
Catherine BrissetteCatherine Brissette
Catherine Brissette
Lyme disease, which is caused by infection withBorrelia burgdorferiand related species, can lead to inflammatory pathologies affecting the joints, heart, and nervous systems including the central nervous system (CNS). Inbred laboratory mice have been used to define the kinetics ofB.burgdorferiinfection and host immune responses in joints and heart, however similar studies are lacking in the CNS of these animals. A tractable animal model for investigating host-Borreliainteractions in the CNS is key to understanding the mechanisms of CNS pathogenesis. Therefore, we characterized the kinetics ofB.burgdorfericolonization and associated immune responses in the CNS of mice during early and subacute infection. Using fluorescence-immunohistochemistry, intravital microscopy, bacterial culture, and quantitative PCR, we foundB.burgdorferiroutinely colonized the dura mater of C3H mice, with peak spirochete burden at day 7 post-infection. Dura mater colonization was observed for several Lyme disease agents includingB.burgdorferi,B.garinii, andB.mayonii. RNA-sequencing and quantitative RT-PCR showed thatB.burgdorferiinfection was associated with increased expression of inflammatory cytokines and a robust interferon (IFN) response in the dura mater. Histopathologic changes including leukocytic infiltrates and vascular changes were also observed in the meninges of infected animals. In contrast to the meninges, we did not detectB.burgdorferi, infiltrating leukocytes, or large-scale changes in cytokine profiles in the cerebral cortex or hippocampus during infection; however, both brain regions demonstrated similar changes in expression of IFN-stimulated genes as observed in peripheral tissues and meninges. Taken together,B.burgdorferiis capable of colonizing the meninges in laboratory mice, and induces localized inflammation similar to peripheral tissues. A sterile IFN response in the absence ofB.burgdorferior inflammatory cytokines is unique to the brain parenchyma, and provides insight into the potential mechanisms of CNS pathology associated with this important pathogen.

25 July 2018 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
Marc D. BassonMarc D. Basson
Marc D. Basson
QWQinggang Wang
Qinggang Wang
LCLakshmi S. Chaturvedi
Lakshmi S. Chaturvedi
SMShyam More
Shyam More
EVEmilie Vomhof-DeKrey
Emilie Vomhof-DeKrey
MKMatti Kiupel
Matti Kiupel
Background/Aims: Human enterocytic differentiation is altered during development, fasting, adaptation, and bariatric surgery, but its intracellular control remains unclear. We hypothesized that Schlafen 12 (SLFN12) regulates enterocyte differentiation. Methods: We used laser capture dissection of epithelium, qRT-PCR, and immunohistochemistry to evaluate SLFN12 expression in biopsies of control and fasting human duodenal mucosa, and viral overexpression and siRNA to trace the SLFN12 pathway in human Caco-2 and HIEC6 intestinal epithelial cells. Results: Fasting human duodenal mucosa expressed less SLFN12 mRNA and protein, accompanied by decreases in enterocytic markers like sucrase-isomaltase. SLFN12 overexpression increased Caco-2 sucrase-isomaltase promoter activity, mRNA, and protein independently of proliferation, and activated the SLFN12 putative promoter. SLFN12 coprecipitated Serpin B12 (SERPB12). An inactivating SLFN12 point mutation prevented both SERPB12 binding and sucrase-isomaltase induction. SERPB12 overexpression also induced sucrase-isomaltase, while reducing SERPB12 prevented the SLFN12 effect on sucrase-isomaltase. Sucrase-isomaltase induction by both SLFN12 and SERPB12 was attenuated by reducing UCHL5 or USP14, and blocked by reducing both. SERPB12 stimulated USP14 but not UCHL5 activity. SERPB12 coprecipitated USP14 but not UCHL5. Moreover, SLFN12 increased protein levels of the sucrase-isomaltase-promoter-binding transcription factor cdx2 without altering Cdx2 mRNA. This was prevented by reducing UCHL5 and USP14. We further validated this pathway in vitro and in vivo. SLFN12 or SERPB12 overexpression induced sucrase-isomaltase in human non-malignant HIEC-6 enterocytes. Conclusions: SLFN12 regulates human enterocytic differentiation by a pathway involving SERPB12, the deubiquitylases, and Cdx2. This pathway may be targeted to manipulate human enterocytic differentiation in mucosal atrophy, short gut or obesity.

22 October 2015 in Nutrition Reviews
Verified
Journal Article
Closed access
PDF file
MPMatthew Picklo
Matthew Picklo
ELEric K. Long
Eric K. Long
EVEmilie Vomhof-DeKrey
Emilie Vomhof-DeKrey
Oxidative stress is associated with obesity. However, glutathione (GSH), one of the body’s most abundant antioxidants, plays dual and seemingly contradictory roles in the development of obesity and its comorbidities. Glutathione has complex metabolic and biochemical fates and is a cofactor for several enzymes that function in modifying obesity-related responses. For example, depletion of GSH increases energy metabolism and reduces adipose accretion, while elevation of GSH peroxidase activity induces insulin resistance. This review summarizes the literature linking GSH and its related enzymes, GSH peroxidase, glutaredoxins, and glutathione S-transferases, to obesity and its pertinent endpoints (e.g., energy metabolism, inflammation, and insulin resistance).

1 June 2014 in Current Opinion in Immunology
Verified
Journal Article
Closed access
EVEmilie Vomhof-DeKrey
Emilie Vomhof-DeKrey
JYJennifer Yates
Jennifer Yates
ELElizabeth A Leadbetter
Elizabeth A Leadbetter